Combining T cells and IL-10: A new therapy for Crohn's disease?

Gastroenterology

Volumn 123, Issue 6, 2002, Pages 2140-2144

  Madsen, Karen ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; GREEN FLUORESCENT PROTEIN; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEOPTERIN; PHYTOHEMAGGLUTININ; RECOMBINANT INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; COLITIS; CROHN DISEASE; CYTOKINE PRODUCTION; EDITORIAL; ENTERITIS; GENE THERAPY; GENE TRANSFER; HUMAN; INFLAMMATION; INTERFERON PRODUCTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ULCERATIVE COLITIS;

EID: 0036893014     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.37289     Document Type: Article

References (41)

1. Sandborn WJ, Targan SR. Biologic therapy of inflammatory bowel disease. Gastroenterology 2002;122:1592-1608.
2. Strober W, Fuss IJ, Blumberg RS. Immunology of mucosal models of inflammation. Ann Rev Immun 2002;20:495-549.
3. Landers CJ, Cohavy O, Misra R, Yang H, Lin Y, Braun J, Targan SR. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto and microbial antigens. Gastroenterology 2002;123:689-699.
4. Fiocchi C. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 1998;115:182-205.
5. Schreiber S. Interleukin-10 in the intestine. Gut 1997;41:274-275.
6. Kramer R, Zhang Y, Gehrmann J, Gold R, Thoenen H, Wekerle H. Gene transfer through the blood-nerve barrier: NGF-engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis. Nat Med 1995;1:1162-1166.
7. Singh B, Read S, Asseman C, Malmstrom V, Mottet C, Stephens LA, Stepankova R, Tlaskalova H, Powrie F. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001;182:190-200.
8. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2001;182:68-79.
9. + T cells. J Exp Med 1993;178:237-244.
10. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. Phenootypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C.B.-17 SCID mice. Int Immunol 1993;5:1461-1471.
11. Hagenbaugh A, Sharma S, Dubinett SM, Wei SH, Aranda R, Cheroutre H, Fowell DJ, Binder S, Tsao B, Locksley RM, Moore FW, Kronenberg M. Altered immune responses in interleukin-10 transgenic mice. J Exp Med 1997;185:2101-2110.
12. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190:995-1004.
13. Mason D, Powrie F. Control of immune pathology by regulatory T cells. Curr Opin Immunol 1998;10:649-655.
14. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-2095.
15. de Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, de Vries JE. Interleukin-10. Curr Opin Immunol 1992;4:314-322.
16. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-274.
17. Tomoyose M, Mitsuyama K, Ishida H, Toyonaga A, Tanikawa K. Role of interleukin-10 in a murine model of dextran sulfate sodium-induced colitis. Scand J Gastroenterol 1998;33:435-440.
18. Ribbons KA, Thompson JH, Lie X, Pennline K, Clark DA, Miller MJ. Anti-inflammatory properties of interleukin-10 administration in hapten-induced colitis. Eur J Pharmacol 1997;323:245-254.
19. Van Deventer SJ, Elson CO, Fedorak RN. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Gastroenterology 1997;113:383-389.
20. Fedorak RN, Gangl A, Elson CO, Rutgeerts P, Schreiber S, Wild G, Hanaver SB, Kilian A, Cohard M, Le Beaut A, Feagan B. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. Gastroenterology 2000;119:1473-1482.
21. Schreiber S, Fedorak RN, Nielsen OG, Wild G, Williams CN, Nikolaus S, Jacyna M, Lashner BA, Gangl A, Rutgeerts P, Isaacs K, van Deventer SJ, Koningsberger JC, Cohard M, Le Beaut A, Hanaver SB. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Gastroenterology 2000;119:1461-1472.
22. Tilg H, van Montfrans C, van den Ende A, Kaser A, van Deventer SJ, Schreiber S, Gregor M, Ludwiczek O, Rutgeerts P, Gasche C, Koningsberger JC, Abreu L, Kuhn I, Cohard M, Le Beaut A, Grint P, Weiss G. Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut 2002;50:191-195.
23. Tilg H, Ulmer H, Kaser A, Weiss G. Role of IL-10 for induction of anemia during inflammation. J Immunol 2002;169:2204-2209.
24. Go NF, Castle BE, Barrett R, Kastelein R, Dang W, Mosmann TR, Moore KW, Howard M. Interleukin 10, a novel B cell stimulatory factor: Unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med 1990;172:1625-1631.
25. MacNeil IA, Suda T, Moore KW. Mosmann TR, Zlotnik A. IL-10, a novel growth cofactor for mature and immature T cells. J Immunol 1990;145:4167-4173.
26. Steidler L, Hans W, Schotte L, Neiryneck S, Oberneier F, Falk W, Fiers W, Remaut E. 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289:1352-1355.
27. Nakase H, Okazaki K, Tabata Y, Ozeki M, Watanabe N, Ohana M, Uose S, Uchida K, Nishi T, Mastuura M, Tamaki H, Itoh T, Kawanami C, Chiba T. New cytokine delivery system using gelatin microspheres containing interleukin-10 for experimental inflammatory bowel disease. J Pharmacol Exp Ther 2002;301:59-65.
28. Van Montfrans C, Hooijberg E, Rodriguez Pena M, de Jong E, Spits H, te Velde A, van Deventer SJH. Generation of regulatory gut-homing human T lymphocytes using ex vivo interleukin 10 gene transfer. Gastroenterology 2002;123:1877-1888.
29. Van Montfrans C, Rodriguez Pena M, Pronk I, ten Kate FJW, te Velde AA, van Deventer SJH. Prevention of colitis by interleukin-10 transduced T lymphocytes in the transfer model. Gastroenterology 2002;123:1865-1876.
30. Ten Hove T, Corbaz A, Amitai H, Aloni S, Belzer I, Graber P, Drillenburg P, van Deventer SJ, Chvatchko Y, Te Velde AA. Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice. Gastroenterology 2001;121:1372-1379.
31. Ribbons KA, Thompson JH, Lie XP, Pennline K, Clark DA, Miller MJS. Anti-inflammatory properties of interleukin-10 administration in hapten-induced colitis. Eur J Pharmacol 1997;323:245-254.
32. Chen LZ, Hochwald GM, Huang C, Dakin G, Tao H, Cheng C, Simmons WJ, Dranoff G, Thorbecke GJ. Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-β1. Proc Natl Acad Sci U S A 1998;95:12516-12521.
33. Setoguchi K, Misaki Y, Araki Y, Fujio K, Kawahata K, Kitamura T, Yamamoto K. Antigen-specific T cells transduced with IL-1O ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen. J Immunol 2000;165:5980-5986.
34. Fnakajima A, Seroogy CM, Sandora MR, Tamer IH, Costa GL Taylor-Edwards C, Bachmann MH, Contag CH, Fathman CG. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J Clin Invest 2001;107:1293-1301.
35. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
36. Lindsay JO, Feldmann M, Hodgson H, Brennan F. The immunoregulatory role of interleukin-10 in Crohn's disease (CD) cell cultures. Gastroenterology 2000;118(Suppl):A110.
37. Colpaert S, Vanstraelen K, Liu Z, Penninckx F, Geboes K, Rutgeerts P, Ceuppens J. Decreased lamina propria effector cell responsiveness to interleukin-10 in ileal Crohn's disease. Clin Immunol 2002;102:68-76.
38. + T cells, but not B cells, mediate colitis in interleukin-10 deficient mice. J Exp Med 1996;184:1567-1572.
39. Barbara G, Xing Z, Hogaboam CM, Gauldie J, Collins SM. Interleukin 10 gene transfer prevents experimental colitis in rats. Gut 2000;46:344-349.
40. Meresse B, Rutgeerts P, Malchow H, Dubucquoi S, Dessaint JP, Cohard M, Colombelo JF, Desreumaux P. Low ileal interleukin 10 concentrations are predictive of endoscopic recurrence in patients with Crohn's disease. Gut 2002;50:25-28.
41. high expression by gut derived T lymphocytes in Crohn's disease and ulcerative colitis (abstr). Gastroenterology 2001;120:A526.